do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation It's the first in a class of drugs called Development of a treatment selection
Description
References 1 AliM
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)
Patients with a history of pancreatitis were excluded from trials, so it is unknown if they are at greater risk

Create legal pathways for experimental treatments that are accessible to people like me
In conclusion, the role of GLP-1RAs in the management of DR remains a nuanced and evolving topic